# Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.

> **NCT00466895** · PHASE1 · COMPLETED · sponsor: **Leslie Andritsos** · enrollment: 37 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** lenalidomide

## Key facts

- **NCT ID:** NCT00466895
- **Lead sponsor:** Leslie Andritsos
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2014-12
- **Final completion:** 2016-07
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466895, "Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00466895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*